Literature summary extracted from

Ruelle, J.; Roman, F.; Vandenbroucke, A.T.; Lambert, C.; Fransen, K.; Echahidi, F.; Pierard, D.; Verhofstede, C.; Van Laethem, K.; Delforge, M.L.; Vaira, D.; Schmit, J.C.; Goubau, P.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database (2008), BMC Infect. Dis., 8, 21.

Protein Variants

EC Number	Protein Variants	Comment	Organism
3.4.23.47	V71I, L90M, I89V	most frequently detected mutations within PR selected under antiretroviral drug therapy in a clinical cohort study with 25 patients treated with antiretroviral therapy	Human immunodeficiency virus 2

Organism

EC Number	Organism	UniProt	Comment	Textmining
3.4.23.47	Human immunodeficiency virus 2	-	isolate EHO subtype B	-

Synonyms

EC Number	Synonyms	Comment	Organism
3.4.23.47	PR	-	Human immunodeficiency virus 2

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)